Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.
The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Department Old Testament receives visiting professor from the USA
2009-05-19

 
Prof. Fanie Snyman (left) and Prof. Leder.


Prof. Arie Leder, professor in Old Testament at the Calvin Theological Seminary, Grand Rapids, Michigan in the United States of America (USA) set foot on the African continent for the first time when he visited Prof. Fanie Snyman of the Department Old Testament in the Faculty of Theology at the University of the Free State (UFS). Prof. Leder is a visiting professor at the Department of Old Testament.

During his two-week-long visit to the faculty he amongst others lectured to undergraduate and master’s students. The lectures addressed issues related to the first five books of the Old Testament with the focus on the interpretation of the Hebrew text. The mentioned historical books of the Old Testament were discussed with the postgraduate students of the faculty. During the meeting of the Discussion Group for Biblical Sciences, Prof. Leder presented a public lecture with the theme, “Lady Wisdom and Sir Folly: Preaching Esther for such a time as this”.

According to Prof. Snyman, the agreement with Prof. Leder was to present the same lectures as what he would have delivered at the Calvin Theological Seminary. “The aim was to compare the standards, course content and presentations of the lectures that are presented by the respective departments, with each other. We compare well with the Calvin Theological Seminary and we do not have to be ashamed of ourselves. The feedback of the students about the exposure to another lecturer from another institution was also positive,” said Prof. Snyman.

The possibility of future collaboration was also discussed, specifically with the objective of both institutions publishing articles in the respective journals of both institutions. A further positive result of Prof. Leder’s visit is that colleagues of the Calvin Theological Seminary will be approached to act as external examiners for postgraduate students,” said Prof. Snyman.

The Calvin Theological Seminary libraries are some of the best equipped theological libraries in the world and as a result of the collaboration between our two institutions, staff of this faculty will get the opportunity to visit the Calvin Institution and to utilise the facility.

Photo: Leonie Bolleurs

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept